Latest Market Expansion News

RemSense Technologies reported a cash flow positive Q3 FY2025 with $420K net cash from operations and $1.403M in customer receipts, underpinned by renewed contracts and strategic partnerships across energy and industrial sectors.

First Graphene Limited reported a successful A$2.4 million capital raise alongside promising progress in its PureGRAPH-CEM product trials in the UK and South Africa, while securing key patents and expanding distribution across Asia and South America.

SportsHero Limited has made significant strides in commercialising its iGV Family Game Pass, securing key partnerships with major Southeast Asian telecom operators and expanding its market footprint to the Philippines.

OncoSil Medical has reported a remarkable 233% increase in dose sales for Q3 FY25, alongside significant regulatory approvals and strategic expansions that position the company for accelerated growth.

Zelira Therapeutics has enhanced its financial flexibility through a $1.15 million R&D tax refund and a $1 million At-the-Market equity facility, while progressing FDA trial preparations for its HOPE® 1 autism treatment.

Identitii Limited advances its BNDRY platform with new agreements targeting hospitality and payments sectors, appoints Tim Phillipps as Executive Chair, and reports stable cash flow amid ongoing patent litigation.

ReNerve Limited reported a 39% sales increase in Q3 FY25 alongside compelling clinical validation of its NervAlign® Nerve Cuff and strategic international partnerships, positioning the company for broader market penetration.

Uscom Limited reported a 14% rise in Q3 customer receipts to $0.73 million, even as cash reserves dropped 38% to $1.34 million, reflecting increased operating costs and global market pressures.

Alexium International Group reported a challenging Q3 FY2025 with lower revenues due to softness in the US bedding market, while making significant technological strides and maintaining a solid funding position.

Nova Eye Medical reported a 27% rise in Q3FY25 sales excluding China, driven by record US performance and a sharp reduction in glaucoma segment losses. The company confirmed FY25 revenue guidance and unveiled plans to expand its iTrack™ technology into ocular drug delivery.

WA Kaolin Limited has ramped up production with new classifiers, achieving record sales and securing a $7 million capital raise, while expanding its footprint in the Chinese market.

Vection Technologies has successfully raised $3.55 million, exceeding its initial $2 million target, following a robust Q3 FY25 performance marked by a 92% increase in cash receipts and a significant boost in recurring revenue.